profit from every £100 of sales.
£0£100
CVS Group
£14.09+0.43% today
+2.0% in 1 year
1-year low £11.141-year high £14.16
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2021 to 2024.
0%20% a year
You pay £146.61 for every £1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What CVS Group sold, what it kept, and what it did with the cash.
Sales went from £510 million in 2021 to £639 million in 2024, with £6.40 million of profit last year.
SalesProfit
CVS Group handed back 26% of the cash it generated last year.
£5M
Free cash flow 2024£25M
Bought back its own shares£900,000
Paid as dividends£5M
Cash vs. debt£17M vs. £288M
CVS Group vs. similar companies
CVS Group grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from £100 of sales | Sales growth a year | Price per £1 of profit |
|---|---|---|---|
| CVS Group | 146.6× · Very expensive | ||
 HCA Healthcare | 15.4× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.7× · Fair price | ||
 IHH Healthcare Berhad | 33.3× · Expensive | ||
 Rede D'Or São Luiz | 15.8× · Fair price |
AI analysis
An AI analyst reads CVS Group's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of GBP | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| 510 | 554 | 589 | 639 | |
| 222 | 239 | 258 | 269 | |
| 40 | 43 | 68 | 48 | |
| 88 | 90 | 118 | 105 | |
| 19 | 26 | 42 | 6 | |
| 0.27 | 0.36 | 0.59 | 0.09 | |
| 43.5% | 43.1% | 43.8% | 42.1% | |
| 7.9% | 7.7% | 11.6% | 7.5% | |
| 3.8% | 4.6% | 7.1% | 1.0% |
Balance sheet
| In millions of GBP | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 485 | 518 | 572 | 690 |
| Cash | 34 | 49 | 22 | 17 |
| Total debt | 183 | 189 | 199 | 288 |
| Total liabilities | 293 | 301 | 315 | 430 |
| 191 | 217 | 257 | 260 | |
| 71 | 72 | 72 | 72 | |
| 8.0% | 7.8% | 11.1% | 6.4% | |
| 10.1% | 11.8% | 16.3% | 2.5% |
Cash flow
| In millions of GBP | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| 60 | 76 | 85 | 68 | |
| 17 | 25 | 46 | 43 | |
| 44 | 51 | 39 | 25 | |
| Dividends paid | – | 5 | 5 | 5 |
| – | 0 | 1 | 1 | |
| 2 | 2 | 2 | 2 |
Valuation
- 146.6×
- –
- –
- 3.3×
- 1.5×
- 38.0×
- 11.5×
- 2.6%
- 0.7%
- 0.6%
Profitability
- 42.1%
- 7.5%
- 1.0%
- –
- 6.4%
- 8.3%
- –
- –
- –
- –
Growth
- +7.8%
- −31.8%
- –
- –
- +0.2%
Financial health
- 2.6×
- 1.11
- –
- 4.0×
- 1.09
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 46%of 952
Bottom 45%of 883
Bottom 3%of 576
Bottom 38%of 870
Top 38%of 985
0.6%of the share price, paid each year
On $1,000 invested$6a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
84.4% of its profit
Room to growStretchedMore than it earns: 21.9%
News
Nebius Group (NBIS) Takes a Beating — This Tech Giant Is to BlameYahoo Finance · Nov 13, 2026Nebius Group (NBIS) Gets Gartner Backing Through A $13 Million AI Platform WinYahoo Finance · Nov 12, 2026What Nebius Group Buyers Were Betting OnYahoo Finance · Nov 10, 2026Analysts are cautious on Lucid Group after earningsSeeking Alpha · Nov 10, 2026Hesai Group reports mixed Q3 results; gives Q4 outlookSeeking Alpha · Nov 10, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
29No pass
Benjamin Graham
28No pass
Philip Fisher
24No pass
Peter Lynch
21No pass
Joel Greenblatt
9No pass
Charlie Munger
14No pass
Terry Smith
17No pass
Questions about CVS Group
Is CVS Group a good stock to buy?
A business with weak numbers, priced as if everything goes right. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the CVS Group AI analysis
What does CVS Group do?
CVS Group plc, together with its subsidiaries, engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia. It operates through the Veterinary Practices, Laboratories, and Online Retail Business segments. It is in Medical Care Facilities, based in Diss, United Kingdom, with 9,000 employees.
Does CVS Group pay a dividend?
Yes. At today's price the dividend is 0.6% a year, about 84% of its yearly profit. In 2024 it paid out £5.40 million in dividends.
Is CVS Group stock halal?
Questionable. CVS Group sits in a grey zone: its debt is 31% of its market value, between 30% and 33%. How we check
How has CVS Group stock done over the past year?
Up 2.0% over the past twelve months, to £14.09. It traded between £11.14 and £14.16, close to its high.
Who are CVS Group's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with CVS Group's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.